Literature DB >> 3193769

Primary carcinoma of the gallbladder: TNM staging and prognosis.

K White1, W G Kraybill, M J Lopez.   

Abstract

In order to investigate the lethality of carcinoma of the gallbladder and several of the coexisting features, a retrospective analysis of 53 patients with this disease was undertaken. Abdominal pain, obstructive jaundice, and a right upper quandrant mass were present in approximately one-half of the patients. Laboratory and radiological data were frequently nonspecific and did little to identify the diagnosis. The most common preoperative diagnoses were cholelithiasis or chronic cholecystitis. Cholecystectomy was the most frequently performed procedure. Fifteen wedge liver resections were performed. No radical or extended liver resections were done. Eighty-one percent of the patients had sufficient data for staging. Five patients (11.6%) had stage I lesions, three patients (7.0%) had stage II lesions, while 17 (39.5%) and 18 (41.9%) patients had stage III and IV lesions, respectively. Mean survival was 6.4 months for the entire group. Three patients are still alive (two longer than 5 years and one at 2 years) for an overall survival of 5.7%. Both staging and grading of the tumor correlated well with patient survival. Those patients with stage I lesions survived significantly longer (23 months vs. 3 months) than those with stage IV tumors. Also, those with more favorably graded (well-differentiated) neoplasms lived an average of 13 months longer than patients with poorly differentiated lesions.

Entities:  

Mesh:

Year:  1988        PMID: 3193769     DOI: 10.1002/jso.2930390407

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

Review 1.  Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread.

Authors:  Amit Nandan Dhar Dwivedi; Shivi Jain; Ruhi Dixit
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

2.  Does radical resection improve the survival in patients with carcinoma of the gallbladder who are 75 years old and older?

Authors:  Hirohiko Onoyama; Tetsuo Ajiki; Moriatsu Takada; Tomoaki Urakawa; Yoichi Saitoh
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

3.  Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.

Authors:  Toru Kawamoto; Junichi Shoda; Naoki Miyahara; Hideo Suzuki; Masato Furukawa; Takeshi Todoroki; Naomi Tanaka; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma.

Authors:  T Todoroki; Y Iwasaki; K Orii; M Otsuka; K Ohara; T Kawamoto; K Nakamura
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

Review 5.  What should I do about my patient's gall stones?

Authors:  A R Dennison; D Azoulay; N Oakley; H Baer; J A Paraskevopoulos; G J Maddern
Journal:  Postgrad Med J       Date:  1995-12       Impact factor: 2.401

6.  Impact of Type of Surgery on Survival Outcome in Patients With Early Gallbladder Cancer in the Era of Minimally Invasive Surgery: Oncologic Safety of Laparoscopic Surgery.

Authors:  Jin-Young Jang; Jin Seok Heo; Youngmin Han; Jihoon Chang; Jae Ri Kim; Hongbeom Kim; Wooil Kwon; Sun-Whe Kim; Seong Ho Choi; Dong Wook Choi; Kyoungbun Lee; Kee-Taek Jang; Sung-Sik Han; Sang-Jae Park
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Management of incidental and suspicious gallbladder cancer: focus on early referral to a tertiary centre.

Authors:  Vincent S Yip; Dhanwant Gomez; Sean Brown; Clare Byrne; David White; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik
Journal:  HPB (Oxford)       Date:  2013-11-27       Impact factor: 3.647

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.